POET - Precision Oncology and Experimental Therapeutics (POET) Protocol
Summary
A program designed to monitor current treatment responses and to develop new strategies to identify tailored therapies for cancer patients.
Our group of researchers proposes to develop new strategies to identify tailored therapies for cancer patients. These strategies are based on analysis of DNA, RNA, metabolomics and microbes from a variety of samples (blood, urine, stool and saliva) that we are asking to collect from you.
Eligibility
Eligible gender: Male, Female, Transgender, Other
Eligible ages: 18 to 100
Inclusion criteria:
1. Confirmed diagnosis of cancer, based on diagnostic imaging reports(e.g CT scan, MRI) or pathology reports (tissue)
2. Undergoing therapy at the Tom Baker Cancer Centre
3. Males or females at least 18 years of age
4. Signed informed consent
Exclusion criteria:
1. Patients unable to provide written, informed consent
Participate
Additional information
Contact information
Prospective participants will be identified by the Medical Oncologists at the TBCC or identified by participation in the SHILED Initiative.
Principal investigator:
Pinaki Bose
Clinical trial:
No
REB-ID:
HREBA.CC-18-0147